Atlas Trials

Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke

Clinical trial NCT01910363 · UNKNOWN

Trial details

NCT number
NCT01910363
Sponsor
University of Tokushima
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Lower Limb Spasticity After Stroke
Start date
2013-07-01
Primary completion
2014-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.